抗腫瘍剤としてのキナゾリン誘導体

Title:

抗腫瘍剤としてのキナゾリン誘導体

Document Type and Number:

Japanese Patent JP2007505874

Kind Code:

A

Abstract:

A quinazoline derivative of the formula (I): (A chemical formula should be inserted here-please see paper copy enclosed) Formula I wherein the substituents are as defined in the text for use in the production of an anti proliferative effect which effect is produced alone or in part by inhibiting erbB2 receptor tyrosine kinase in a warm blooded animal such as man.

More Like This:

WO/2007/139967	TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY
JP7104690	Heterocyclic apelin receptor (APJ) agonists and their use
JP4340985	N, N', N'''-Tris {2,4-bis [(1-hydrocarbyloxy-2,2,6,6-tetramethylpiperidine-4-yl) alkylamino] -s-triazine-6- Il} -3,3'-ethylenediiminodipropylamine, its isomers and crosslinked derivatives and thus stabilized polymer compositions

Inventors:

Bradbury, Robert Hugh
Hennekin, Laurent Francois Andre
Kettle, Jason Grant

Application Number:

JP2006526685A

Publication Date:

March 15, 2007

Filing Date:

September 14, 2004

Export Citation:

Click for automatic bibliography generation Help

Assignee:

AstraZeneca Activrag

International Classes:

C07D401/14; A61K31/517; A61K31/5377; A61P9/10; A61P13/08; A61P17/06; A61P35/00; A61P35/02; A61P43/00; C07D401/12; C07D403/12; C07D403/14; C07D413/12; C07D413/14; C07D417/14; C07B61/00

Domestic Patent References:

JP2006525296A

2006-11-09

Foreign References:

WO2003040109A2	2003-05-15
WO2003040108A1	2003-05-15

Attorney, Agent or Firm:

Kazuo Shamoto
Shinjiro Ono
Yasushi Kobayashi
Akio Chiba
Hiroyuki Tomita
Takumi Terachi

Previous Patent: チロシンキナーゼ阻害剤としてのキナゾリン誘導体

Next Patent: キナゾリン誘導体